Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer

NCT01216020 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

70

Enrollment

OTHER

Sponsor class

Stopped insufficient recruitment

Conditions

Head and Neck Neoplasms
Laryngeal Neoplasms
Mouth Neoplasms
Pharyngeal Neoplasms

Interventions

DRUG: cetuximab
DRUG: cisplatin (associated to radiotherapy)

Sponsor

Azienda USL 4 Prato

Collaborators

[object Object]